Group One Trading’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-100
| Closed | -$1K | – | 9090 |
|
|
2021
Q3 | $1K | Buy |
+100
| New | +$1.46K | ﹤0.01% | 8071 |
|
|
2021
Q2 | – | Sell |
-200
| Closed | -$36K | – | 8748 |
|
|
2021
Q1 | $36K | Buy |
+200
| New | +$3.45K | ﹤0.01% | 6449 |
|
|
2020
Q4 | – | Sell |
-1,000
| Closed | -$12K | – | 7204 |
|
|
2020
Q3 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 5362 |
|
|
2020
Q2 | $15K | Buy |
1,000
+800
| +400% | +$11.8K | ﹤0.01% | 4967 |
|
|
2020
Q1 | $3K | Sell |
200
-600
| -75% | -$11.4K | ﹤0.01% | 4923 |
|
|
2019
Q4 | $19K | Sell |
800
-70,200
| -99% | -$1.45M | ﹤0.01% | 4387 |
|
|
2019
Q3 | $1.36M | Sell |
71,000
-3,800
| -5% | -$87.1K | 0.01% | 1498 |
|
|
2019
Q2 | $2.21M | Buy |
+74,800
| New | +$2.88M | 0.02% | 1006 |
|
|
2019
Q1 | – | Sell |
-32,200
| Closed | -$1.16M | – | 5557 |
|
|
2018
Q4 | $1.16M | Hold |
32,200
| – | – | 0.01% | 1395 |
|
|
2018
Q3 | $1.98M | Sell |
32,200
-20,400
| -39% | -$1.31M | 0.02% | 1170 |
|
|
2018
Q2 | $3.55M | Buy |
52,600
+40,800
| +346% | +$2.28M | 0.03% | 731 |
|
|
2018
Q1 | $640K | Sell |
11,800
-11,600
| -50% | -$649K | 0.01% | 1860 |
|
|
2017
Q4 | $1.4M | Buy |
23,400
+9,500
| +68% | +$576K | 0.01% | 1441 |
|
|
2017
Q3 | $676K | Buy |
13,900
+6,300
| +83% | +$344K | 0.01% | 1847 |
|
|
2017
Q2 | $399K | Sell |
7,600
-67,500
| -90% | -$3.14M | ﹤0.01% | 2132 |
|
|
2017
Q1 | $3.41M | Buy |
75,100
+58,700
| +358% | +$2.62M | 0.04% | 571 |
|
|
2016
Q4 | $621K | Sell |
16,400
-60,700
| -79% | -$2.3M | 0.01% | 1638 |
|
|
2016
Q3 | $2.91M | Buy |
+77,100
| New | +$1.7M | 0.03% | 661 |
|
|
2016
Q2 | – | Sell |
-1,000
| Closed | -$12K | – | 5043 |
|
|
2016
Q1 | $12K | Sell |
1,000
-16,200
| -94% | -$256K | ﹤0.01% | 3960 |
|
|
2015
Q4 | $419K | Sell |
17,200
-95,700
| -85% | -$2.23M | 0.01% | 1958 |
|
|
2015
Q3 | $2M | Buy |
112,900
+65,700
| +139% | +$1.19M | 0.03% | 780 |
|
|
2015
Q2 | $833K | Buy |
47,200
+46,500
| +6,643% | +$852K | 0.01% | 1362 |
|
|
2015
Q1 | $22K | Buy |
+700
| New | +$20.3K | ﹤0.01% | 3842 |
|
Group One Trading's AERI Position: Q4 2022 in Review
Group One Trading sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,576 shares — an estimated $24K sold.
Group One Trading first reported a position in AERI in Q2 2015 and held it in 16 quarters. The position peaked at $2.03M in Q2 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Group One Trading reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Group One Trading sold 1,576 Aerie Pharmaceuticals shares in Q4 2022, an estimated $24K.
- Group One Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 16 quarters.
- Group One Trading's Aerie Pharmaceuticals position peaked at $2.03M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.